{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:50:11Z","timestamp":1759333811434,"version":"build-2065373602"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Changzhou Sci & Tech Program","award":["CE20235061","CJ20220131"],"award-info":[{"award-number":["CE20235061","CJ20220131"]}]},{"name":"Changzhou High-Level Medical Talents Training Project","award":["2022CZBJ077"],"award-info":[{"award-number":["2022CZBJ077"]}]},{"name":"Changzhou Medical Center Project","award":["CMCB202226"],"award-info":[{"award-number":["CMCB202226"]}]},{"name":"Changzhou Municipal Health Commission Youth Talent Project","award":["CZQM2023016"],"award-info":[{"award-number":["CZQM2023016"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82000678"],"award-info":[{"award-number":["82000678"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11591-1","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:54:35Z","timestamp":1759161275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of preoperative and postoperative HPV infection dynamics in patients with cervical intraepithelial neoplasia and cervical cancer: implications for screening and management"],"prefix":"10.1186","volume":"25","author":[{"given":"Tongbao","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wuwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"11591_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","volume":"41","author":"HW Chesson","year":"2014","unstructured":"Chesson HW, Dunne EF, Hariri S, Markowitz LE. The estimated lifetime probability of acquiring human papillomavirus in the united States. Sex Transm Dis. 2014;41:660\u20134.","journal-title":"Sex Transm Dis"},{"key":"11591_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/v9090248","volume":"9","author":"D Soto","year":"2017","unstructured":"Soto D, Song C, McLaughlin-Drubin ME. Epigenetic alterations in human Papillomavirus-associated cancers. Viruses. 2017;9:248.","journal-title":"Viruses"},{"key":"11591_CR3","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001540","volume":"102","author":"JA Scarth","year":"2021","unstructured":"Scarth JA, Patterson MR, Morgan EL, Macdonald A. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation. J Gen Virol. 2021;102:001540.","journal-title":"J Gen Virol"},{"key":"11591_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/aje\/kwn036","volume":"168","author":"J Koshiol","year":"2008","unstructured":"Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168:123\u201337.","journal-title":"Am J Epidemiol"},{"key":"11591_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16:1\u201317.","journal-title":"Clin Microbiol Rev"},{"key":"11591_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382:889\u201399.","journal-title":"Lancet"},{"key":"11591_CR7","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"11591_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584\u201390.","journal-title":"Chin Med J"},{"key":"11591_CR9","first-page":"3484","volume":"100","author":"CF Xia","year":"2020","unstructured":"Xia CF, Qiao YL, Zhang Y, Zhao FH. WHO\u2019s global strategy of cervical cancer elimination and the challenges and initiatives in China. Zhonghua Yi Xue Za Zhi. 2020;100:3484\u20138.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"11591_CR10","first-page":"321","volume":"70","author":"ETH Fontham","year":"2020","unstructured":"Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70:321\u201346.","journal-title":"CA Cancer J Clin"},{"key":"11591_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/ijc.31326","volume":"143","author":"A Del Mistro","year":"2018","unstructured":"Del Mistro A, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Girlando S, et al. Human papilloma virus genotyping for the cross-sectional and longitudinal probability of developing cervical intraepithelial neoplasia grade 2 or more. Int J Cancer. 2018;143:333\u201342.","journal-title":"Int J Cancer"},{"key":"11591_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28414","volume":"95","author":"A Ros\u00e1rio","year":"2023","unstructured":"Ros\u00e1rio A, Sousa A, Marinho-Dias J, Medeiros R, Lobo C, Le\u00e7a L, et al. Impact of high-risk human papillomavirus genotyping in cervical disease in the Northern region of Portugal: real-world data from regional cervical cancer screening program. J Med Virol. 2023;95:e28414.","journal-title":"J Med Virol"},{"key":"11591_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijgo.13406","volume":"152","author":"Y Li","year":"2021","unstructured":"Li Y, Wang H, Zhang Y, Jing X, Wu N, Hou Y, Hao C. Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade. Int J Gynaecol Obstet. 2021;152:96\u2013102.","journal-title":"Int J Gynaecol Obstet"},{"key":"11591_CR14","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/ijc.24528","volume":"125","author":"N Wentzensen","year":"2009","unstructured":"Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, et al. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009;125:2151\u20138.","journal-title":"Int J Cancer"},{"key":"11591_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518\u201327.","journal-title":"N Engl J Med"},{"key":"11591_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ygyno.2013.12.040","volume":"132","author":"AF Rositch","year":"2014","unstructured":"Rositch AF, Soeters HM, Offutt-Powell TN, Wheeler BS, Taylor SM, Smith JS. The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review. Gynecol Oncol. 2014;132:767\u201379.","journal-title":"Gynecol Oncol"},{"key":"11591_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13050381","volume":"13","author":"M Rykkelid","year":"2024","unstructured":"Rykkelid M, Wennberg HM, Richardsen E, S\u00f8rbye SW. Post-conization HPV vaccination and its impact on viral status: a retrospective cohort study in Troms and Finnmark, 2022. Pathogens. 2024;13:381.","journal-title":"Pathogens"},{"key":"11591_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1054\/bjoc.2000.1689","volume":"84","author":"MA Nobbenhuis","year":"2001","unstructured":"Nobbenhuis MA, Meijer CJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Risse EK, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer. 2001;84:796\u2013801.","journal-title":"Br J Cancer"},{"key":"11591_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12879-023-08634-w","volume":"23","author":"Q Luo","year":"2023","unstructured":"Luo Q, Zeng X, Luo H, Pan L, Huang Y, Zhang H, Han N. Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions. BMC Infect Dis. 2023;23:667.","journal-title":"BMC Infect Dis"},{"key":"11591_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12985-018-1003-x","volume":"15","author":"W Long","year":"2018","unstructured":"Long W, Yang Z, Li X, Chen M, Liu J, Zhang Y, et al. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix. Virol J. 2018;15:94.","journal-title":"Virol J"},{"key":"11591_CR21","doi-asserted-by":"publisher","first-page":"10680","DOI":"10.1128\/JVI.01747-15","volume":"89","author":"AA Chen","year":"2015","unstructured":"Chen AA, Gheit T, Franceschi S, Tommasino M, Clifford GM. Human papillomavirus 18 genetic variation and cervical cancer risk worldwide. J Virol. 2015;89:10680\u20137.","journal-title":"J Virol"},{"key":"11591_CR22","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1054\/bjoc.2001.1845","volume":"84","author":"C Clavel","year":"2001","unstructured":"Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer. 2001;84:1616\u201323.","journal-title":"Br J Cancer"},{"key":"11591_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0304-3835(03)00312-4","volume":"198","author":"SA Lee","year":"2003","unstructured":"Lee SA, Kang D, Seo SS, Jeong JK, Yoo KY, Jeon YT, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett. 2003;198:187\u201392.","journal-title":"Cancer Lett"},{"key":"11591_CR24","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1128\/JCM.00087-13","volume":"51","author":"M Schmitt","year":"2013","unstructured":"Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M. Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities. J Clin Microbiol. 2013;51:1458\u201364.","journal-title":"J Clin Microbiol"},{"key":"11591_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/LGT.0000000000000487","volume":"23","author":"A D Iacobone","year":"2019","unstructured":"Iacobone A D, Bottari F, Radice D, Preti E P, Franchi D, VU A M, et al. Distribution of High-Risk human papillomavirus genotypes and multiple infections in preneoplastic and neoplastic cervical lesions of unvaccinated women: A Cross-sectional study. J Lower Genit Tract Dis. 2019;23:259\u201364.","journal-title":"J Lower Genit Tract Dis"},{"key":"11591_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12885-018-4330-9","volume":"18","author":"H Wang","year":"2018","unstructured":"Wang H, Cheng X, Ye J, Xu X, Hong Y, Sui L, et al. Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China. BMC Cancer. 2018;18:487.","journal-title":"BMC Cancer"},{"key":"11591_CR27","doi-asserted-by":"publisher","first-page":"e055470","DOI":"10.1136\/bmjopen-2021-055470","volume":"12","author":"M Yang","year":"2022","unstructured":"Yang M, Du J, Lu H, Xiang F, Mei H, Xiao H. Global trends and age-specific incidence and mortality of cervical cancer from 1990 to 2019: an international comparative study based on the global burden of disease. BMJ Open. 2022;12:e055470.","journal-title":"BMJ Open"},{"key":"11591_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","volume":"364","author":"J Peto","year":"2004","unstructured":"Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364:249\u201356.","journal-title":"Lancet"},{"key":"11591_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106276","volume":"144","author":"A Portnoy","year":"2021","unstructured":"Portnoy A, Pedersen K, Trogstad L, Hansen BT, Feiring B, Laake I, et al. Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: a model-based analysis. Prev Med. 2021;144:106276.","journal-title":"Prev Med"},{"key":"11591_CR30","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","volume":"121","author":"LS Massad","year":"2013","unstructured":"Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121:829\u201346.","journal-title":"Obstet Gynecol"},{"key":"11591_CR31","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00404-012-2493-1","volume":"286","author":"N Duesing","year":"2012","unstructured":"Duesing N, Schwarz J, Choschzick M, Jaenicke F, Gieseking F, Issa R, et al. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP). Arch Gynecol Obstet. 2012;286:1549\u201354.","journal-title":"Arch Gynecol Obstet"},{"key":"11591_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ygyno.2013.09.002","volume":"131","author":"CF Gosvig","year":"2013","unstructured":"Gosvig CF, Huusom LD, Andersen KK, Iftner A, Cederkvist L, Svare E, et al. Persistence and reappearance of high-risk human papillomavirus after conization. Gynecol Oncol. 2013;131:661\u20136.","journal-title":"Gynecol Oncol"},{"key":"11591_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3802\/jgo.2009.20.2.91","volume":"20","author":"K Nam","year":"2009","unstructured":"Nam K, Chung S, Kim J, Jeon S, Bae D. Factors associated with HPV persistence after conization in patients with negative margins. J Gynecol Oncol. 2009;20:91\u20135.","journal-title":"J Gynecol Oncol"},{"key":"11591_CR34","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/ijc.24794","volume":"126","author":"YT Kim","year":"2010","unstructured":"Kim YT, Lee JM, Hur SY, Cho CH, Kim YT, Kim SC, et al. Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia. Int J Cancer. 2010;126:1903\u20139.","journal-title":"Int J Cancer"},{"key":"11591_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.30623","volume":"141","author":"SR Hoffman","year":"2017","unstructured":"Hoffman SR, Le T, Lockhart A, Sanusi A, Dal Santo L, Davis M, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): a systematic review. Int J Cancer. 2017;141:8\u201323.","journal-title":"Int J Cancer"},{"key":"11591_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ygyno.2007.11.009","volume":"108","author":"JY Park","year":"2008","unstructured":"Park JY, Lee KH, Dong SM, Kang S, Park SY, Seo SS. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence\/recurrence of cervical intraepithelial neoplasia after conization. Gynecol Oncol. 2008;108:549\u201354.","journal-title":"Gynecol Oncol"},{"key":"11591_CR37","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.ajog.2009.01.005","volume":"201","author":"S Brismar","year":"2009","unstructured":"Brismar S, Johansson B, Borjesson M, Arbyn M, Andersson S. Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping. Am J Obstet Gynecol. 2009;201:e171\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"11591_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0090-8258(03)00372-X","volume":"90","author":"V Houfflin Debarge","year":"2003","unstructured":"Houfflin Debarge V, Collinet P, Vinatier D, Ego A, Dewilde A, Boman F, et al. Value of human papillomavirus testing after conization by loop electrosurgical excision for high-grade squamous intraepithelial lesions. Gynecol Oncol. 2003;90:587\u201392.","journal-title":"Gynecol Oncol"},{"key":"11591_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ijgo.12106","volume":"137","author":"L Giannella","year":"2017","unstructured":"Giannella L, Fodero C, Boselli F, Rubino T, Mfuta K, Prandi S. Age-related changes in pre- and post-conization HPV genotype distribution among women with high-grade cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2017;137:72\u20137.","journal-title":"Int J Gynaecol Obstet"},{"key":"11591_CR40","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10096-006-0172-5","volume":"25","author":"R Tachezy","year":"2006","unstructured":"Tachezy R, Mikyskov\u00e1 I, Ludv\u00edkov\u00e1 V, Rob L, Kucera T, Slav\u00edk V, et al. Longitudinal study of patients after surgical treatment for cervical lesions: detection of HPV DNA and prevalence of HPV-specific antibodies. Eur J Clin Microbiol Infect Dis. 2006;25:492\u2013500.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11591-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:02:32Z","timestamp":1759190552000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11591-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11591"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11591-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"6 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the affiliated Changzhou Second People\u2019s Hospital of Nanjing Medical University ([2023]KY204-01). The need for patient consent was waived by the Ethics Committee because of the retrospective nature of this study and the use of deidentified data. All study procedures were performed in accordance with the relevant guidelines and regulations of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1195"}}